Agness Nhidza-Manjoro

SANTHE Post-doctoral Fellow

Collaborative Clinical Research Centre (CCRC), Harare, Zimbabwe


Post COVID-19 Syndrome: Inflammatory Indicators in a cohort of recovered COVID-19 patients to assess the role of continued Inflammatory process amongst SARS-CoV-2 infection survivors

Collaboration Interests
  • Cohort Creation
  • Proposal Writing (immunogenetics of infectious diseases)
  • Setting up of immunogenomic research laboratory in Zimbabwe (research support centre)

Agness Nhidza, born and raised in Zimbabwe, studied her PhD in Medical Microbiology at the University of KwaZulu-Natal (UKZN) in Durban, South Africa, focussing on immune responses to asymptomatic enteric pathogens. She is currently employed as a Quality Systems Manager/ Senior Laboratory Scientist by the Biomedical Research and Training Institute in Harare, Zimbabwe, and is now interested in understanding immunology of infectious diseases such as in long COVID. Her Post-doctoral studies focus on establishing a cohort of individuals that have been, or are, exposed to COVID-19 and will be followed up over time to study their immune responses to disease and post disease. Nhidza would like to investigate the possibility of using inflammatory markers as predictive tools to identify patients most likely to suffer from long COVID. A predictor tool that identifies patients likely to suffer from long COVID-19 will impact patient management plans and improve time to recovery and survival. The output from this study will also inform the development of diagnostic tools to quickly diagnose/exclude long COVID-19 and improve clinical management of post-COVID patients.

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.